Here are the S-1 registration statements from Iveda Solutions, Inc. Warrant (IVDAW) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-1 covers the registration statement a company files to sell shares publicly, so if you follow IVDAW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IVDAW filings page.
Iveda Solutions, Inc. has filed an amended S-1 to offer up to 5,434,782 shares of common stock, together with up to 5,434,782 pre-funded warrants and up to 5,434,782 Series X warrants to buy up to 10,869,564 additional shares, on a reasonable best efforts basis. The assumed combined price is $0.92 per share and accompanying Series X warrants, matching the last Nasdaq Capital Market close on January 28, 2026.
The company, recently redomiciled to Delaware, develops AI-driven video analytics and IoT-based smart city platforms, with most revenue generated by its Taiwan subsidiary. It has a going concern opinion, accumulated losses of about $51 million through December 31, 2024, and relies heavily on a small number of key customers. There is no minimum offering amount or escrow, so investor funds become immediately available even if limited capital is raised, and the new securities will dilute existing holders, with common shares outstanding rising from 5,879,741 to 11,314,523 if all shares (but no warrants) are sold.
Iveda Solutions, Inc. is conducting a reasonable best efforts primary offering of up to 5,434,782 shares of common stock at an assumed combined price of $0.92 per share together with Series X warrants to purchase up to 10,869,564 additional shares. The company may instead issue up to 5,434,782 pre-funded warrants in lieu of common stock for investors constrained by 4.99% or 9.99% ownership limits, with each pre-funded warrant exercisable at $0.0001 per share.
The Series X warrants are exercisable upon issuance at $0.92 per share and expire two years after issuance. Common stock outstanding was 5,879,741 shares before the offering and is expected to be 11,314,523 shares after the offering, excluding existing options and warrants. Iveda highlights significant risks, including a going concern opinion, accumulated losses of roughly $51–53 million, heavy reliance on its Taiwan subsidiary for most revenue, customer concentration, and the possibility of Nasdaq delisting if listing standards are not maintained.